Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-23 Purchase | 2022-05-25 5:12 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 85,262 | $2.3153 | $197,404 | 2,594,952 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-20 6:01 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 13,073 | $2.3046 | $30,128 | 2,509,690 (Direct) | View |
| 2022-05-12 Purchase | 2022-05-16 7:31 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 84,836 | $2.2884 | $194,143 | 2,496,617 (Direct) | View |
| 2022-05-10 Purchase | 2022-05-11 6:38 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 45,575 | $2.2848 | $104,128 | 2,411,781 (Direct) | View |
| 2022-05-05 Purchase | 2022-05-09 5:44 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 124,122 | $2.2765 | $282,563 | 2,366,206 (Direct) | View |
| 2022-04-28 Purchase | 2022-05-02 7:03 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 33,614 | $2.3124 | $77,730 | 2,242,084 (Direct) | View |
| 2022-04-25 Purchase | 2022-04-27 6:33 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 13,751 | $2.2913 | $31,508 | 2,208,470 (Direct) | View |
| 2022-04-18 Purchase | 2022-04-20 7:43 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 9,119 | $2.3117 | $21,080 | 2,187,219 (Direct) | View |
| 2022-04-14 Purchase | 2022-04-14 8:04 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 17,410 | $2.3289 | $40,546 | 2,171,100 (Direct) | View |
| 2022-04-08 Purchase | 2022-04-12 7:31 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 104,713 | $2.318 | $242,729 | 2,153,690 (Direct) | View |
| 2022-04-05 Purchase | 2022-04-07 8:38 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 103,984 | $2.3059 | $239,778 | 2,048,977 (Direct) | View |
| 2022-04-04 Purchase(A) | 2022-04-07 8:36 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 122,342 | $2.2585 | $276,309 | 1,944,993 (Direct) | View |
| 2022-04-04 Purchase | 2022-04-04 8:26 pm | ARCA biopharma Inc. | ABIO | Funicular Fund LP See Footnote 1 | 122,342 | $2.2585 | $276,309 | 1,944,993 (Direct) | View |
| 2021-11-22 Purchase | 2021-11-23 4:53 pm | ARCA biopharma Inc. | ABIO | Ozeroff Christopher David S.V.P., General Counsel | 50,000 | $2.2642 | $113,210 | 50,970 (Direct) | View |
| 2021-05-12 Purchase | 2021-05-13 5:00 pm | ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board | 10,000 | $3.1947 | $31,947 | 50,000 (Direct) | View |
| 2021-05-05 Purchase | 2021-05-06 4:30 pm | ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board | 10,000 | $3.2345 | $32,345 | 40,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-15 Option Award | 2022-12-19 5:33 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 6,000 | $0 | 4,048,452 (Direct) | View |
| 2022-12-16 Exercise | 2022-12-19 5:33 pm | 2022-12-16 2022-12-16 | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 14,200 | $0 | 4,048,452 (Direct) | View |
| 2022-12-16 Expired | 2022-12-19 5:33 pm | 2022-12-16 2022-12-16 | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 300 | $0 | 4,048,452 (Direct) | View |
| 2022-12-16 Exercise | 2022-12-19 5:33 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 1,420,000 | $2.5 | 4,048,452 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:30 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:24 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | MITCHELL DANIEL J Director | 6,000 | $0 | 6,611 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:24 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Grais Linda Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:23 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Hove Anders D Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:20 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board | 6,000 | $0 | 56,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:19 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Flynn James P Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-12-08 Option Award | 2022-12-09 4:30 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Keuer Thomas A Chief Operating Officer | 40,000 | $0 | 40,730 (Direct) | View |
| 2022-12-08 Option Award | 2022-12-09 4:30 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-07-01 Other | 2022-07-08 7:17 pm | 2022-12-16 2022-12-16 | ARCA biopharma Inc. | ABIO | Funicular Funds LP See Footnote 1 10% Owner | 2,609,452 | $0 | 11,771,808 (Indirect) | View |
Ownership | 2022-07-08 7:12 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Funicular Funds LP See Footnote 1 10% Owner | 0 | $0 | 4,030,452 (Indirect) | View |
| 2022-06-15 Option Award | 2022-06-21 7:42 pm | N/A 2032-06-15 | ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See Footnote 1 10% Owner | 12,000 | $0 | 4,042,452 (Direct) | View |
Ownership | 2022-06-21 7:40 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See Footnote 1 10% Owner | 0 | $0 | 4,030,452 (Indirect) | View |
Ownership(A) | 2022-04-07 8:33 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 | 0 | $0 | 1,822,651 (Direct) | View |
Ownership | 2022-04-04 8:22 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Funicular Fund LP See Footnote 1 | 0 | $0 | 1,822,651 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 4:33 pm | N/A 2031-12-14 | ARCA biopharma Inc. | ABIO | Ozeroff Christopher David S.V.P., General Counsel | 27,500 | $0 | 78,470 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 4:32 pm | N/A 2031-12-14 | ARCA biopharma Inc. | ABIO | Keuer Thomas A Chief Operating Officer | 35,000 | $0 | 35,730 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 4:31 pm | N/A 2031-12-14 | ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer | 17,700 | $0 | 17,700 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 4:31 pm | N/A 2031-12-14 | ARCA biopharma Inc. | ABIO | BRISTOW MICHAEL R Pres. & Chief Executive Offic | 95,000 | $0 | 99,808 (Direct) | View |
Ownership | 2021-05-11 4:35 pm | N/A 2031-05-10 | ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer | 0 | $0 | 55,000 (Direct) | View |
| 2021-01-12 Option Award | 2021-01-13 7:07 pm | N/A 2031-01-12 | ARCA biopharma Inc. | ABIO | Hove Anders D Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-01-12 Option Award | 2021-01-13 7:06 pm | N/A 2031-01-12 | ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-01-12 Option Award | 2021-01-13 7:06 pm | N/A 2031-01-12 | ARCA biopharma Inc. | ABIO | Grais Linda Director | 12,000 | $0 | 12,000 (Direct) | View |